All currency values in € millions unless otherwise noted
| Income Statement | DEC 2024 | DEC 2023 | DEC 2022 |
|---|---|---|---|
| Revenues | |||
| Revenue | €4 | €0 | €0 |
| Cost of Revenue | €3 | €2 | €2 |
| Gross Profit | €1 | -€2 | -€2 |
| Total Operating Expenses | €15 | €13 | €12 |
| Operating Income | -€15 | -€15 | -€14 |
| Non-Operating | |||
| Net Interest Expense | -€1 | -€0 | -€1 |
| Income Tax Expense | -€0 | -€0 | -€0 |
| Net Income | |||
| Net Income | -€15 | -€16 | -€15 |
| Per Share Data | |||
| Revenue Per Share | €0.11 | €0.00 | €0.00 |
| EPS (Basic) | -€0.38 | -€0.51 | -€0.81 |
| EPS (Diluted) | -€0.38 | -€0.51 | -€0.81 |
| Shares Outstanding | 39.2M | 30.7M | 18.9M |
Carvolix SA (CVX.XPAR) financials: revenue, profit and margins
Carvolix SA (CVX.XPAR) generated about €4 million in revenue and -€15 million in net income (a -357.9% net margin) over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Carvolix SA's (CVX.XPAR) revenue?+
Carvolix SA generated about €4 million in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Carvolix SA profitable?+
Carvolix SA reported about -€15 million in net loss over the trailing twelve months, a net margin of roughly -357.9%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Carvolix SA's profit margins?+
Carvolix SA runs a gross margin of about 20.8%, an operating margin of about -355.4%, a net margin of about -357.9%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Peers
Medical Devices · Pick stocks to compare with CVX.XPAR
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CVX.XPAR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.